Shannon Morris
Technik-/Wissenschafts-/F&E-Leiter bei ERASCA, INC.
Vermögen: - $ am 30.04.2024
Profil
Shannon R.
Morris is currently the President & Partner at Sigma Group, Inc. and the Chief Medical Officer at Erasca, Inc. Prior to these roles, Dr. Morris held positions as the Senior Director at Medimmune, Inc. from 2014 to 2017, the Vice President & Head-Clinical Development at Istari Oncology, Inc. from 2020 to 2022, and the Vice President-Clinical Development at G1 Therapeutics, Inc. from 2017 to 2020.
Dr. Morris completed their undergraduate degree at Stanford University and their doctorate degree at Case Western Reserve University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ERASCA, INC.
-.--% | 05.02.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Shannon Morris
| Unternehmen | Position | Beginn |
|---|---|---|
| ERASCA, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.05.2022 |
Sigma Group, Inc.
 Sigma Group, Inc. Advertising/Marketing ServicesCommercial Services Sigma Group, Inc. provides advertising services. It offers business to business, consumer packaged goods and retail services. The company was founded by Vladimir Chronis in 1986 and is headquartered in Upper Saddle River, NJ. | Präsident | - |
Ehemalige bekannte Positionen von Shannon Morris
| Unternehmen | Position | Ende |
|---|---|---|
Istari Oncology, Inc.
 Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 |
| G1 THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2020 |
| Medimmune, Inc. | Direktor/Vorstandsmitglied | 01.03.2017 |
Ausbildung von Shannon Morris
| Case Western Reserve University | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ERASCA, INC. | Health Technology |
| G1 THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Istari Oncology, Inc.
Istari Oncology, Inc. BiotechnologyHealth Technology Istari Oncology, Inc. operates as a clinical-stage biotechnology company. It focuses on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. Its core technology assets are PVS-RIPO, a prototypic oncolytic recombinant polio virus vaccine, and a series of antibody-drug conjugates comprising antibodies or antibody fragments to a variety of oncology targets. The company was founded by Darell D. Bigner and Matthias Gromeier in 2016 and is headquartered in Research Triangle Park, NC. | Health Technology |
Sigma Group, Inc.
Sigma Group, Inc. Advertising/Marketing ServicesCommercial Services Sigma Group, Inc. provides advertising services. It offers business to business, consumer packaged goods and retail services. The company was founded by Vladimir Chronis in 1986 and is headquartered in Upper Saddle River, NJ. | Commercial Services |
| Medimmune, Inc. | Health Technology |
